Novavax (NVAX)
NASDAQ:NVAX

Novavax (NVAX) Financial Statements

7,868 Followers

Novavax Financial Overview

Novavax's market cap is currently ―. The company's EPS TTM is $-8.449; its P/E ratio is -0.73; Novavax is scheduled to report earnings on May 8, 2023, and the estimated EPS forecast is $-3.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 628.30M$ 78.15M$ 604.67M$ 222.20M
Gross Profit-$ 193.71M$ -192.93M$ 589.47M-
EBIT-$ -161.97M$ -502.83M$ 210.59M$ -824.54M
EBITDA-$ -153.63M$ -496.11M$ 217.35M$ -820.87M
Net Income Common Stockholders-$ -168.61M$ -510.49M$ 203.41M$ -846.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 1.28B$ 1.38B$ 1.57B$ 1.52B
Total Assets-$ 2.27B$ 2.62B$ 2.83B$ 2.58B
Total Debt$ 0.00$ 438.09M$ 448.43M$ 440.50M$ 453.99M
Net Debt$ 0.00$ -842.49M$ -927.16M$ -1.13B$ -1.06B
Total Liabilities-$ 2.83B$ 3.04B$ 2.77B$ 2.93B
Stockholders Equity$ 0.00$ -565.99M$ -416.95M$ 65.32M$ -351.67M
Cash Flow-
Free Cash Flow-$ -68.23M$ -195.48M$ -105.34M$ -358.77M
Operating Cash Flow-$ -38.71M$ -170.90M$ -88.51M$ -342.41M
Investing Cash Flow-$ -29.52M$ -24.58M$ -16.83M$ -16.36M
Financing Cash Flow-$ -30.98M$ 4.66M$ 159.87M$ -60.71M
Currency in USD

Novavax Earnings and Revenue History


Novavax Debt to Assets


Novavax Cash Flow


Novavax Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis